Interleukin (IL)-10 attenuates lipopolysaccharide-induced IL-6 production via inhibition of IκB-ζ activity by Bcl-3

Abstract

The inhibitory effect of interleukin-10 (IL-10), an anti-inflammatory cytokine, on lipopolysaccharide (LPS)-induced IL-6 production was characterized by simultaneous stimulation of RAW 264.7 cells with LPS and IL-10. The presence of IL-10 significantly inhibited LPS-induced IL-6 production at a transcriptional level. The expression of IκB-ζ, which promotes IL-6 production, was induced in response to LPS and it was definitely suppressed in the presence of IL-10. Further, IL-10 inhibited LPS-induced NF-κB activation. A pharmacological inhibitor of NF-κB prevented LPS-induced IκB-ζ expression, suggesting that IL-10 might inhibit LPS-induced IκB-ζ expression via the inactivation of NF-κB. In LPS- and IL-10-stimulated cells, the expression of Bcl-3 that inhibits NF-κB activation was significantly augmented. Introduction of Bcl-3 siRNA abolished IL-10-mediated IκB-ζ inhibition. In the presence of Bcl-3, siRNA IL-10 failed to inhibit LPS-induced IL-6 production. Therefore, it was suggested that Bcl-3 induced by IL-10 might reduce LPS-induced IκB-ζ activity via inactivation of NF-κB and that reduced IκB-ζ activity failed to promote LPS-induced IL-6 production.

Keywords

Bcl-3 IL-10 IL-6 LPS IκB-ζ

References

Moore KW , de Waal Malefyt R. , Coffman RL , O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.

Donnelly RP , Freeman SL , Hayes MP Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. J Immunol 1995 ; 155: 1420-1427.

Bogdan C. , Paik J. , Vodovotz Y. , Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992; 267: 23301-23308.

Schottelius AJ , Mayo MW , Sartor RB , Baldwin Jr AS Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding . J Biol Chem 1999; 274: 31868-31874.

Williams L. , Bradley L. , Smith A. , Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 2004; 172: 567-576.

Wang P. , Wu P. , Siegel MI , Egan RW , Billah MM Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995; 270: 9558-9563.

Kontoyiannis D. , Kotlyarov A. , Carballo E. et al. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology . EMBO J 2001; 20: 3760-3770.

Qasimi P. , Ming-Lum A. , Ghanipour A. et al. Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor-alpha and nitric oxide production by macrophages . J Biol Chem 2006; 281: 6316-6324.

Berlato C. , Cassatella MA , Kinjyo I. , Gatto L. , Yoshimura A. , Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation . J Immunol 2002; 168: 6404-6411.

10.

Wessells J. , Baer M. , Young HA et al. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages . J Biol Chem 2004; 279: 49995-50003.

11.

Akira S. , Taga T. , Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993; 54: 1-78.

12.

O'Neill LA How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006; 18: 3-9.

13.

Akira S. , Takeda K. Toll-like receptor signaling. Nat Rev Immunol 2004; 4: 499-511.

14.

Beutler B. Inferences, questions and possibilities in Toll-like receptor signaling . Nature 2004; 430: 257-263.

15.

Kitamura H. , Kanehira K. , Shiina T. et al. Bacterial lipopolysaccharide induces mRNA expression of an IkappaB MAIL through Toll-like receptor 4. J Vet Med Sci 2002; 64: 419-422.

16.

Yamamoto M. , Yamazaki S. , Uematsu S. et al. Regulation of Toll/IL-1-receptor mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 2004; 430: 218-222.

17.

Kitamura H. , Kanehira K. , Okita K. , Morimatsu M. , Saito M. MAIL, a novel nuclear I kappa B protein that potentiates LPS-induced IL-6 production. FEBS Lett 2000; 485: 53-56.

18.

Yamazaki S. , Muta T. , Matsuo S. , Takeshige K. Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/interleukin-1 receptor is mediated by mRNA stabilization . J Biol Chem 2005; 280: 1678-1687.

19.

Trinh DV , Zhu N. , Farhang G. , Kim BJ , Huxford T. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA. J Mol Biol 2008; 379: 122-135.

20.

Dagvadorj J. , Naiki Y. , Tumurkhuu G. et al. Interleukin-10 inhibits tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW 264. 7 cells through reduced MyD88 expression . Innate Immun 2008; 14: 109-115.

21.

Nolan GP , Fujita T. , Bhatia K. et al. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol 1993; 13: 3557-3566.

22.

Turkson J. , Ryan D. , Kim JS et al. Phosphotyrosyl peptides block Stat3 mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem 2001; 276: 45443-45455.

23.

Mühlbauer M. , Chilton PM , Mitchell TC , Jobin C. Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(-/-) mice. J Biol Chem 2008; 283: 14182-14189.

24.

Caamaño JH , Perez P. , Lira SA , Bravo R. Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NFkappaB1 (p50) homodimers in vivo. Mol Cell Biol 1996; 16: 1342-1348.

25.

Yamazaki S. , Muta T. , Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J Biol Chem 2001; 276: 27657-27662.

26.

Totzke G. , Essmann F. , Pohlmann S. A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding. J Biol Chem 2006 ; 281: 12645-12654.

27.

Muta T. IkappaB-zeta: an inducible regulator of nuclear factorkappaB. Vitam Horm 2006; 74: 301-316.

28.

Yamamoto M. , Takeda K. Role of nuclear IkappaB proteins in the regulation of host immune responses. J Infect Chemother 2008; 14: 265-269.

29.

Kuwata H. , Watanabe Y. , Miyoshi H. et al. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 2003; 102: 4123-4129.

30.

Eto A. , Muta T. , Yamazaki S. , Takeshige K. Essential roles for NF-kappa B and a Toll/IL-1 receptor domain-specific signal(s) in the induction of I kappa B-zeta. Biochem Biophys Res Commun 2003; 301: 495-501.